Grzegorz Pasternak
David Aebisher
Rafal Filip
Dorota Bartusik-Aebisher
Inflammatory bowel disease: clinical aspects
Grzegorz Pasternak
David Aebisher
Rafal Filip
Dorota Bartusik-Aebisher
Department of Gastroenterology, Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszow, Poland
Department of Photomedicine and Physical Chemistry, Medical College of Rzeszów University, Rzeszów, Poland
Department of Gastroenterology, Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszow, Poland
Department of Biochemistry and General Chemistry, Medical College of the University of Rzeszow, University of Rzeszow, Rzeszow, Poland
Received: 11 June 2018 / Accepted: 27 August 2018 / Published: 30 December 2018
Abstract
Introduction. Inflammatory bowel disease is a complex disease which arises as a result of an interaction between environmental and genetic factors leading to immunological responses and inflammation in the intestine.
Aim. To review medical approaches used in inflammatory bowel disorders.
Material and methods. An analysis of literature regarding inflammatory bowel diseases, Leśniowski-Crohn’s disease, ulcerative colitis and mataloproteinases.
Results. Current evidence suggests that patients with inflammatory bowel disease may have an elevated risk of endothelial dysfunction and coronary artery disease. Over the past two decades, great advances have been made in our understanding of the interplay between the inflammatory bowel disease.
Conclusion. Inflammatory bowel diseases are increasing in Europe. The diagnosis is usually confirmed by biopsies on colonoscopy.
Cite
Pasternak G, David Aebisher D, Filip R, Bartusik-Aebisher D. Inflammatory bowel disease: clinical aspects. Eur J Clin Exp Med. 2018;16(4):341–345. doi: 10.15584/ejcem.2018.4.12
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited